Target intelligence / Profile preview

Mycobacterium tuberculosis cell membrane and energetics

Molecular classification
Enzyme, Transporter, Oxidoreductase, ATP synthase
01

Overview

The Mycobacterium tuberculosis cell membrane and energetics target refers to the integrated biochemical pathways and structural components responsible for maintaining the electrochemical gradient and generating ATP in M. tuberculosis [1]. This system includes the electron transport chain (ETC), comprising complexes such as NADH dehydrogenase (NDH-1 and NDH-2), the cytochrome bc1:aa3 oxidase complex, and the F1F0-ATP synthase [2][3]. These components are essential for the survival of the pathogen in both its actively replicating and dormant (non-replicating) states, as the maintenance of a proton motive force is required even when the bacteria are not growing [4]. Drugs targeting this system, most notably bedaquiline, have revolutionized the treatment of multidrug-resistant tuberculosis by specifically inhibiting mycobacterial energy production [5]. Because these targets are often distinct from their human mitochondrial counterparts, they provide a high degree of selectivity, although concerns such as QT prolongation remain a clinical challenge [6].

Other names
Mtb respiratory chainMtb oxidative phosphorylation systemMtb bioenergeticsMtb electron transport chain
02

Mechanism of action

Inhibition of mycobacterial F1F0-ATP synthase [1]; Inhibition of the cytochrome bc1:aa3 complex (QcrB subunit) [2]; Disruption of the proton motive force and membrane potential [3]; Respiratory poisoning via nitric oxide release [4].

03

Biological functions

ATP synthesisCellular respirationMaintenance of membrane potentialOxidative phosphorylationProton motive force maintenance
04

Disease associations

Infection
05

Safety considerations

QT interval prolongationHepatotoxicitySkin discoloration (Clofazimine)Long terminal half-life leading to tissue accumulation
06

Interacting drugs

Bedaquiline

4 more in the full profile.

07

Biomarkers

Sputum culture conversionTime to positivity (TTP) in liquid cultureUrinary lipoarabinomannan (LAM)

Beyond the preview

Go deeper on Mycobacterium tuberculosis cell membrane and energetics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium tuberculosis cell membrane and energetics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call